Immuneering Corp IMRX:NASDAQ

RT Quote | NASDAQ | USD
Last | 08/18/22 EDT
7.00quote price arrow down-0.12 (-1.69%)
Volume
6,098
52 week range
3.74 - 33.25
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close7.00
  • 52 Week High33.25
  • 52 Week High Date09/27/21
  • 52 Week Low3.74
  • 52 Week Low Date05/25/22

Key Stats

  • Market Cap184.73M
  • Shares Out26.39M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-56.71

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close7.00
  • 52 Week High33.25
  • 52 Week High Date09/27/21
  • 52 Week Low3.74
  • 52 Week Low Date05/25/22
  • Market Cap184.73M
  • Shares Out26.39M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-56.71

RATIOS/PROFITABILITY

  • EPS (TTM)-1.68
  • P/E (TTM)-4.17
  • Fwd P/E (NTM)-3.28
  • EBITDA (TTM)-40.483M
  • ROE (TTM)-69.60%
  • Revenue (TTM)1.52M
  • Gross Margin (TTM)44.92%
  • Net Margin (TTM)-2,652.82%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/09/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Immuneering Corp

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
Immuneering Corporation is a biopharmaceutical company. The Company is focused on improving patient outcomes by advancing a pipeline of oncology and neuroscience product candidates developed using its translational bioinformatics platform. Its development programs in oncology are focused on providing treatments for patients with solid tumors caused by mutations of the MAPK and mTOR pathways. Its lead product candidate, IMM-1-104, is designed to be a selective dual-MEK...
Robert Carpenter
Independent Chairman of the Board, Co-Founder
Benjamin Zeskind Ph.D.
President, Chief Executive Officer, Co-Founder, Director
Mallory Morales
Chief Financial Officer, Treasurer
Michael Bookman
General Counsel, Secretary
Address
245 Main St Fl 2
Cambridge, MA
02142
United States

Top Peers

SYMBOLLASTCHG%CHG
OVID
Ovid Therapeutics Inc
2.25+0.07+3.21%
VIRX
Viracta Therapeutics Inc
4.15+0.09+2.22%
TSHA
Taysha Gene Therapies Inc
3.88-0.06-1.52%
CELC
Celcuity Inc
9.84-0.16-1.60%
PDSB
PDS Biotechnology Corp
4.99-0.28-5.31%